Membrane technology

Global Extracorporeal Membrane Oxygenation Machine Market (2021 to 2028) - Share, Size, Trends & Industry Analysis Report - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 5, 2021

b'The "Extracorporeal Membrane Oxygenation Machine Market Share, Size, Trends, Industry Analysis Report, By Component; By Modality; By Patient Type; By Application; By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com\'s offering.\nThe global extracorporeal membrane oxygenation (ECMO) machine market size is expected to reach USD 307.5 million by 2028 according to a new study.

Key Points: 
  • b'The "Extracorporeal Membrane Oxygenation Machine Market Share, Size, Trends, Industry Analysis Report, By Component; By Modality; By Patient Type; By Application; By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com\'s offering.\nThe global extracorporeal membrane oxygenation (ECMO) machine market size is expected to reach USD 307.5 million by 2028 according to a new study.
  • The report gives a detailed insight into current market dynamics and provides analysis on future market growth.\nThe growing old age population, with the rising prevalence of coronary heart disorders, is boosting the adoption of the uptake of Extracorporeal Membrane Oxygenation Machine (ECMO).
  • This is the first of its kind of extracorporeal membrane oxygenation machine, manufactured by Fresenius Medical Care North America, to be used as life support for patients.
  • The kit is comprised of a blood purification cartridge and tubing connector set, which allows hassle-free integration in the currently available extracorporeal membrane oxygenation machines in the market.\n'

Rockwell Medical, Inc. to Report First Quarter 2021 Financial and Operating Results on May 17, 2021

Retrieved on: 
Monday, May 3, 2021

A live webcast of the call will be available under "Events & Presentations" in the Investor section of the Company\'s website, https://ir.rockwellmed.com/ .

Key Points: 
  • A live webcast of the call will be available under "Events & Presentations" in the Investor section of the Company\'s website, https://ir.rockwellmed.com/ .
  • The Company has two FDA-approved therapies indicated for patients undergoing hemodialysis, which are the first two products developed from the FPC platform.
  • Rockwell Medical is also advancing its FPC platform by developing FPC for the treatment of iron deficiency anemia in patients outside of dialysis, who are receiving intravenous medications in the home infusion setting.
  • In addition, Rockwell Medical is one of two major suppliers of life-saving hemodialysis concentrate products to kidney dialysis clinics in the United States.

Global Tertiary Water and Wastewater Treatment Technologies Market to 2027 - Featuring Xylem, 3M and Pentair Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, April 30, 2021

b'The "Tertiary Water and Wastewater Treatment Technologies Market by Type (Membrane Filtration, UV Radiation, Chlorination, Ozonization, Activated Carbon, and Ion Exchange), and Application (Municipal and Industrial) - Global Forecast to 2027" report has been added to ResearchAndMarkets.com\'s offering.\nThis report provides an in-depth analysis of the tertiary water and wastewater treatment technologies market across five major geographies and emphasizes on the current market trends, market size, market shares, recent developments, and forecast till 2027.

Key Points: 
  • b'The "Tertiary Water and Wastewater Treatment Technologies Market by Type (Membrane Filtration, UV Radiation, Chlorination, Ozonization, Activated Carbon, and Ion Exchange), and Application (Municipal and Industrial) - Global Forecast to 2027" report has been added to ResearchAndMarkets.com\'s offering.\nThis report provides an in-depth analysis of the tertiary water and wastewater treatment technologies market across five major geographies and emphasizes on the current market trends, market size, market shares, recent developments, and forecast till 2027.
  • The Tertiary Water and Wastewater Treatment Technologies Market is expected to reach $35.5 billion by 2027, at a CAGR of 7.2% during the forecast period, 2020-2027.\nThe growth of this market is mainly attributed to the rapid population growth and urbanization, the rising need for new water resources, and the increasing prevalence of waterborne diseases are also a few of the key factors driving the growth of the tertiary water and wastewater treatment technologies market.\nThe study offers a comprehensive analysis of the tertiary water and wastewater treatment technologies market with respect to the type (membrane filtration {MF & UF}, reverse osmosis, UV radiation {UV & UV-H2O2}, chlorination, ozonization, activated carbon {GAC & PAC}, ion exchange, electrochemical water treatment technology, and other treatment technologies), application (municipal and industrial {manufacturing, pharmaceuticals & chemicals, power, energy, pulp & paper, mining, petrochemicals, semiconductors, and other industrial applications}), and geography.
  • The study also evaluates industry competitors and analyzes the market at the country level.\n'

United States Consumer Water Treatment Market Report 2021: Historical Data for 2009, 2014, and 2019 and Forecasts to 2024 and 2029 - ResearchAndMarkets.com

Retrieved on: 
Friday, April 30, 2021

b'The "Consumer Water Treatment" report has been added to ResearchAndMarkets.com\'s offering.\nThis study covers the United States consumer market for water treatment systems primarily designed to decrease the amount of contaminants and minerals in households\' water.

Key Points: 
  • b'The "Consumer Water Treatment" report has been added to ResearchAndMarkets.com\'s offering.\nThis study covers the United States consumer market for water treatment systems primarily designed to decrease the amount of contaminants and minerals in households\' water.
  • Systems purchased by consumers for personal use outside of the home (e.g., during leisure activities, pleasure, work, or school) are also considered, as are consumables, such as replacement filters, membranes, and salt.\nRefrigerator water filters and pitchers are excluded because these systems are originally sold to equipment manufacturers and only the replacement units are sold to consumers.\nKey breakouts for consumer water treatment systems include technology, system, and region.\nreverse osmosis and other membranes (e.g., ultrafiltration, microfiltration)\n'

Global Reverse Osmosis Membrane Market Report 2021: Demand for RO Membrane is Mainly Driven by it's Application for Seawater Desalination

Retrieved on: 
Thursday, April 29, 2021

Reverse Osmosis is the water purification method to filter out impurities, and all contaminants, leaving only the pure usable water.

Key Points: 
  • Reverse Osmosis is the water purification method to filter out impurities, and all contaminants, leaving only the pure usable water.
  • The RO membranes are typically capable of removing 90%-99% of contaminants or impurities such as total dissolved solids (TDSs) and viruses from the water.
  • The demand for RO membrane is mainly driven by its application for the seawater desalination.\nThe global reverse osmosis membrane market is majorly driven by factors such as water shortage across the globe, growing need of desalination in water scarce regions, and increasing government emphasis on ensuring the water quality.
  • Contradictorily, rise in demand for water treatment across the developing nations is expected to create ample opportunities for reverse osmosis membrane market growth.\nIn terms of geography, North America held major share of the market in 2019.

Nephria Bio signs exclusive agreement with Drexel University to license new "MXene" nanomaterial for future dialysis innovations

Retrieved on: 
Thursday, April 29, 2021

MXenes are attracting increasing attention along with graphene as an ideal 2D material.

Key Points: 
  • MXenes are attracting increasing attention along with graphene as an ideal 2D material.
  • The advantages of MXenes are numerous but include superior biocompatibility, sieving coefficient and higher urea binding affinity, all properties which make them an ideal fit for application to dialysis.
  • The system could supplement/bridge traditional dialysis therapy and, ultimately, supplant it, depending upon device performance and therapeutic needs.\nOnce more efficient cartridges and wearable dialysis therapiesare developed, high demand in the market is expected.
  • Nephria Bio secured them both- the proprietary electroosmotic pump technology from EOFlow, and the filter technology from Drexel University," Jesse Kim, founding CEO of Nephria Bio said.\n"With the unique combination of these enabling technologies, Nephria Bio feels that it can substantially enhance dialysis therapy for kidney patients.

Outset Medical to Present at BofA Securities 2021 Virtual Health Care Conference

Retrieved on: 
Tuesday, April 27, 2021

b'Outset Medical, Inc. (Nasdaq: OM) (\xe2\x80\x9cOutset\xe2\x80\x9d), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021 at 11:45am PT / 2:45pm ET.\nOutset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis.

Key Points: 
  • b'Outset Medical, Inc. (Nasdaq: OM) (\xe2\x80\x9cOutset\xe2\x80\x9d), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021 at 11:45am PT / 2:45pm ET.\nOutset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis.
  • The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers.
  • Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone.
  • Tablo is a registered trademark of Outset Medical, Inc.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210427006034/en/\n'

Rockwell Medical Announces Marketing Approval of Triferic® AVNU™ in Canada

Retrieved on: 
Tuesday, April 27, 2021

Rockwell Medical expects Triferic AVNU to become commercially available in Canada during 2022.\n\xe2\x80\x9cThe approval of Triferic AVNU by Health Canada is the first international regulatory approval for our intravenous therapy and marks important progress for our strategy to bring Triferic to markets around the world,\xe2\x80\x9d said Russell Ellison, M.D., M.Sc., President and Chief Executive Officer of Rockwell Medical.

Key Points: 
  • Rockwell Medical expects Triferic AVNU to become commercially available in Canada during 2022.\n\xe2\x80\x9cThe approval of Triferic AVNU by Health Canada is the first international regulatory approval for our intravenous therapy and marks important progress for our strategy to bring Triferic to markets around the world,\xe2\x80\x9d said Russell Ellison, M.D., M.Sc., President and Chief Executive Officer of Rockwell Medical.
  • Triferic Dialysate and Triferic AVNU have a unique and differentiated mechanism of action, which has the potential to benefit patients and health care economics.
  • Triferic and Triferic AVNU address a significant medical need in treating functional iron deficiency in end-stage kidney disease patients.\nThe safety profile of Triferic is similar to placebo in controlled clinical trials in patients with end-stage kidney disease.
  • Rockwell Medical expressly disclaims any obligation to update our forward-looking statements, except as may be required by law.\nTriferic\xc2\xae is a registered trademark of Rockwell Medical, Inc. Triferic AVNU is pending with the U.S. Patent and Trademark Office.

Dialysis Market Revenue to Cross USD 114 Bn by 2027: Global Market Insights Inc.

Retrieved on: 
Tuesday, April 27, 2021

b'SELBYVILLE, Del., April 27, 2021 /PRNewswire/ --According to the latest report "Dialysis Market by Type (Hemodialysis, Peritoneal Dialysis), Product & Service (Equipment, Consumables, Services), End-use (In-center Dialysis, Home Dialysis), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2027", by Global Market Insights Inc., the market valuation of dialysis will cross $114 billion by 2027.

Key Points: 
  • b'SELBYVILLE, Del., April 27, 2021 /PRNewswire/ --According to the latest report "Dialysis Market by Type (Hemodialysis, Peritoneal Dialysis), Product & Service (Equipment, Consumables, Services), End-use (In-center Dialysis, Home Dialysis), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2027", by Global Market Insights Inc., the market valuation of dialysis will cross $114 billion by 2027.
  • Similarly, availability of efficient dialysis services in dialysis centers and home settings has led to an increased demand for such services among the patient population for effective patient care.\nHome dialysis segment in the dialysis market accounted for more than USD 24 billion in 2020.
  • Additionally, home dialysis offers numerous benefits including flexible schedule, and patient mobility that further secures the segment growth.\nAsia Pacific dialysis market captured over 27% of revenue share in 2020.
  • These market leaders are focusing on developing innovative products that helps the company increase its revenue share internationally.\nTable of Contents (ToC) of the report:\n'

Global Reverse Osmosis Membrane Market Report 2021: Opportunity Analysis and Industry Forecast, 2019-2030 - ResearchAndMarkets.com

Retrieved on: 
Monday, April 26, 2021

Reverse Osmosis is the water purification method to filter out impurities, and all contaminants, leaving only the pure usable water.

Key Points: 
  • Reverse Osmosis is the water purification method to filter out impurities, and all contaminants, leaving only the pure usable water.
  • The RO membranes are typically capable of removing 90%-99% of contaminants or impurities such as total dissolved solids (TDSs) and viruses from the water.
  • Contradictorily, rise in demand for water treatment across the developing nations is expected to create ample opportunities for reverse osmosis membrane market growth.\nIn terms of geography, North America held major share of the market in 2019.
  • However, Asia pacific is expected to grow rapidly with increasing market size due to upsurge in population along with the lack of potable water in several countries across the region.\nMaximum growth opportunities make the reverse osmosis membrane market highly competitive.